Oncology cuts













































































































Lilly has an Oncology Division? Surely you jest?

Yes they do, but you have obviously never been a part of it!

Until recently, Lilly Oncology was selling three agents in a myriad of combinations and indications in the most serious of situations, metastatic cancer.

And as for that one product, it is very doubtfull you could have ever understood or communicated what a folate analog metabolic inhibitor does (arguably the simplist of the three) nor do it with the maturity this position requires (your immature comments make that clear!).

Lilly Oncology must keep top talent to be ready for the introduction of new agents in the future. I wish them well in that challenge. In the meantime - go back to the baby pool!